These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22166630)

  • 21. IMP3 can predict aggressive behaviour of lung adenocarcinoma.
    Beljan Perak R; Durdov MG; Capkun V; Ivcevic V; Pavlovic A; Soljic V; Peric M
    Diagn Pathol; 2012 Nov; 7():165. PubMed ID: 23190601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas.
    Riener MO; Fritzsche FR; Clavien PA; Pestalozzi BC; Probst-Hensch N; Jochum W; Kristiansen G
    Hum Pathol; 2009 Oct; 40(10):1377-83. PubMed ID: 19467694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
    Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
    Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Annexin A1 protein expression in human gastric adenocarcinoma using proteomics and tissue microarray.
    Zhang ZQ; Li XJ; Liu GT; Xia Y; Zhang XY; Wen H
    World J Gastroenterol; 2013 Nov; 19(43):7795-803. PubMed ID: 24282368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of IMP3 and p53 in inflammatory lesions and neoplastic lesions of the gastric mucosa.
    Strehl JD; Hoegel J; Hornicek I; Hartmann A; Riener MO
    Int J Clin Exp Pathol; 2014; 7(5):2091-101. PubMed ID: 24966917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IMP3 expression in gastric cancer: association with clinicopathological features and HER2 status.
    Damasceno EA; Carneiro FP; Magalhães AV; Carneiro Mde V; Takano GH; Vianna LM; Seidler HB; Castro TM; Muniz-Junqueira MI; Amorim RF; Ferreira VM; Motoyama AB
    J Cancer Res Clin Oncol; 2014 Dec; 140(12):2163-8. PubMed ID: 25323937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma.
    Elpek GO; Gelen T; Aksoy NH; Karpuzoglu T; Keles N
    Pathol Oncol Res; 2000; 6(1):59-64. PubMed ID: 10749590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of immunogenic cell death biomarker rage and early growth response 1 in human primary gastric adenocarcinoma.
    Xu XC; Gao H; Zhang WB; Abuduhadeer X; Wang YH
    Int J Immunopathol Pharmacol; 2013; 26(2):485-93. PubMed ID: 23755764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer.
    Sjekloča N; Tomić S; Mrklić I; Vukmirović F; Vučković L; Lovasić IB; Maras-Šimunić M
    Medicine (Baltimore); 2020 Feb; 99(7):e19091. PubMed ID: 32049813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlation between aneuploidy of chromosome 17, over-expression of TP53 and TOPIIalpha, and the clinicopathological features and diagnosis of gastric adenocarcinoma].
    Lu HZ; Wu YP; Luo W; Han YL; Cai Y; Xu X; Liang J; Liu SM; Wang MR
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):754-8. PubMed ID: 20021828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
    Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
    Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinoma.
    Chen YL; Jeng YM; Hsu HC; Lai HS; Lee PH; Lai PL; Yuan RH
    Int J Surg; 2013; 11(1):85-91. PubMed ID: 23246869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of overexpression of nestin with expression of epithelial-mesenchymal transition-related proteins in gastric adenocarcinoma.
    Liu JK; Chen WC; Ji XZ; Zheng WH; Han W; An J
    Asian Pac J Cancer Prev; 2015; 16(7):2777-83. PubMed ID: 25854362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma.
    Wang J; Shen H; Fu G; Zhao D; Wang W
    Oncotarget; 2017 Feb; 8(6):9442-9450. PubMed ID: 28038462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced Expression of Deubiquitinase USP33 Is Associated with Tumor Progression and Poor Prognosis of Gastric Adenocarcinoma.
    Chen Y; Pang X; Ji L; Sun Y; Ji Y
    Med Sci Monit; 2018 May; 24():3496-3505. PubMed ID: 29802710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Martrilin-3 (MATN3) Overexpression in Gastric Adenocarcinoma and its Prognostic Significance.
    Wu PL; He YF; Yao HH; Hu B
    Med Sci Monit; 2018 Jan; 24():348-355. PubMed ID: 29343680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus.
    Plum PS; Ulase D; Bollschweiler E; Chon SH; Berlth F; Zander T; Alakus H; Hölscher AH; Bruns CJ; Schallenberg S; Quaas A; Loeser H
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1731-1739. PubMed ID: 29974234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.
    Chromecki TF; Cha EK; Pummer K; Scherr DS; Tewari AK; Sun M; Fajkovic H; Roehrborn CG; Ashfaq R; Karakiewicz PI; Shariat SF
    BJU Int; 2012 Jul; 110(1):63-8. PubMed ID: 22077633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low level of FOXL1 indicates a worse prognosis for gastric cancer patients.
    Ertao Z; Jianhui C; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C; Hui W
    Tumour Biol; 2016 Aug; 37(8):11331-7. PubMed ID: 26960689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is a marker that predicts presence of invasion in papillary biliary tumors.
    Sasaki M; Sato Y
    Hum Pathol; 2017 Apr; 62():152-159. PubMed ID: 28089541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.